142 related articles for article (PubMed ID: 29459035)
1. Human Interactomics: Comparative Analysis of Different Protein Interaction Resources and Construction of a Cancer Protein-Drug Bipartite Network.
De Las Rivas J; Alonso-López D; Arroyo MM
Adv Protein Chem Struct Biol; 2018; 111():263-282. PubMed ID: 29459035
[TBL] [Abstract][Full Text] [Related]
2. Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View.
Dar KB; Bhat AH; Amin S; Anjum S; Reshi BA; Zargar MA; Masood A; Ganie SA
Curr Cancer Drug Targets; 2019; 19(6):430-448. PubMed ID: 30073927
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Lethality-based Identification of Targets for Anticancer Drugs in the Human Signaling Network.
Liu L; Chen X; Hu C; Zhang D; Shao Z; Jin Q; Yang J; Xie H; Liu B; Hu M; Ke K
Sci Rep; 2018 May; 8(1):8440. PubMed ID: 29855504
[TBL] [Abstract][Full Text] [Related]
4. Protein interactions: mapping interactome networks to support drug target discovery and selection.
De Las Rivas J; Prieto C
Methods Mol Biol; 2012; 910():279-96. PubMed ID: 22821600
[TBL] [Abstract][Full Text] [Related]
5. INTEGRATING GENETIC AND STRUCTURAL DATA ON HUMAN PROTEIN KINOME IN NETWORK-BASED MODELING OF KINASE SENSITIVITIES AND RESISTANCE TO TARGETED AND PERSONALIZED ANTICANCER DRUGS.
Verkhivker GM
Pac Symp Biocomput; 2016; 21():45-56. PubMed ID: 26776172
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
Li Y; Sahni N; Yi S
Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
[TBL] [Abstract][Full Text] [Related]
7. Oncogenes and tumor suppressor genes: comparative genomics and network perspectives.
Zhu K; Liu Q; Zhou Y; Tao C; Zhao Z; Sun J; Xu H
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S8. PubMed ID: 26099335
[TBL] [Abstract][Full Text] [Related]
8. Targeting protein-protein interactions as an anticancer strategy.
Ivanov AA; Khuri FR; Fu H
Trends Pharmacol Sci; 2013 Jul; 34(7):393-400. PubMed ID: 23725674
[TBL] [Abstract][Full Text] [Related]
9. Distinctive Behaviors of Druggable Proteins in Cellular Networks.
Mitsopoulos C; Schierz AC; Workman P; Al-Lazikani B
PLoS Comput Biol; 2015 Dec; 11(12):e1004597. PubMed ID: 26699810
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Architecture of Deregulated Protein Complexes in Cancer.
Stefan E; Troppmair J; Bister K
Adv Protein Chem Struct Biol; 2018; 111():101-132. PubMed ID: 29459029
[TBL] [Abstract][Full Text] [Related]
11. Discovering distinct functional modules of specific cancer types using protein-protein interaction networks.
Shen R; Wang X; Guda C
Biomed Res Int; 2015; 2015():146365. PubMed ID: 26495282
[TBL] [Abstract][Full Text] [Related]
12. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
13. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
14. Path2enet: generation of human pathway-derived networks in an expression specific context.
Droste C; De Las Rivas J
BMC Genomics; 2016 Oct; 17(Suppl 8):731. PubMed ID: 27801297
[TBL] [Abstract][Full Text] [Related]
15. MEDICI: Mining Essentiality Data to Identify Critical Interactions for Cancer Drug Target Discovery and Development.
Harati S; Cooper LA; Moran JD; Giuste FO; Du Y; Ivanov AA; Johns MA; Khuri FR; Fu H; Moreno CS
PLoS One; 2017; 12(1):e0170339. PubMed ID: 28118365
[TBL] [Abstract][Full Text] [Related]
16. Protein-protein interaction networks: unraveling the wiring of molecular machines within the cell.
De Las Rivas J; Fontanillo C
Brief Funct Genomics; 2012 Nov; 11(6):489-96. PubMed ID: 22908212
[TBL] [Abstract][Full Text] [Related]
17. From protein interaction networks to novel therapeutic strategies.
Jaeger S; Aloy P
IUBMB Life; 2012 Jun; 64(6):529-37. PubMed ID: 22573601
[TBL] [Abstract][Full Text] [Related]
18. The OncoPPi Portal: an integrative resource to explore and prioritize protein-protein interactions for cancer target discovery.
Ivanov AA; Revennaugh B; Rusnak L; Gonzalez-Pecchi V; Mo X; Johns MA; Du Y; Cooper LAD; Moreno CS; Khuri FR; Fu H
Bioinformatics; 2018 Apr; 34(7):1183-1191. PubMed ID: 29186335
[TBL] [Abstract][Full Text] [Related]
19. The design and development of covalent protein-protein interaction inhibitors for cancer treatment.
Cheng SS; Yang GJ; Wang W; Leung CH; Ma DL
J Hematol Oncol; 2020 Mar; 13(1):26. PubMed ID: 32228680
[TBL] [Abstract][Full Text] [Related]
20. Analyzing of Molecular Networks for Human Diseases and Drug Discovery.
Hao T; Wang Q; Zhao L; Wu D; Wang E; Sun J
Curr Top Med Chem; 2018; 18(12):1007-1014. PubMed ID: 30101711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
